High-risk AML

This short collection of expert insights on high-risk AML has been selected from EBMT and EHA 2020 symposia featuring the latest data presented by Prof Thomas Cluzeau, Prof Nigel Russell and Dr Donal McLornan. Watch here.

Also watch the individual segments below:

1. Identifying high-risk AML*

2. Should patients with high-risk AML* be transplanted?

3. Long term remission in high-risk AML*

4. New 5 year follow up data for Vyxeos Liposomal

5. Real World Evidence for Vyxeos Liposomal